viewGenetic Technologies

Genetic Technologies’ shares surge on launching promotional campaign

The company’s lead product is a risk assessment test for non-hereditary breast cancer.

a woman getting a breast examination
Genetic Technologies markets BREVAGenplus through its U.S. subsidiary

Genetic Technologies (ASX:GTG) has launched a three-month promotional campaign in conjunction with Breast Cancer Awareness Month which takes place throughout October 2017.

The company’s shares were last trading 33% higher intra-day, at US$0.008.

Genetic Technologies’ lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer.

The test assesses both clinical risk factors and genetic markers known to be associated with non-hereditary breast cancer to determine a woman's five-year risk of developing the disease.

As part of the promotion, the BREVAGenplus test will be offered at a special reduced price of US$199.00 compared to its standard list price of US$349.00.

In April 2017, BREVAGenplus was repositioned from a traditional reimbursement system, through insurance providers, to a direct patient self-pay program.

The initiative was implemented to better serve healthcare providers and patients by providing a streamlined, easy to use billing and payment system.

Genetic Technologies markets BREVAGenplus, through its U.S. subsidiary Phenogen Sciences Inc., to healthcare professionals in comprehensive breast health care and imaging centres.

The company also markets to obstetricians/gynaecologists and breast cancer risk assessment specialists.

Quick facts: Genetic Technologies

Price: 0.0055 AUD

Market: ASX
Market Cap: $39.68 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Arizona Silver Exploration will be going back to Philadelphia after drilling...

Arizona Silver Exploration (TSXV: AZS) (OTCQB: AZASF) VP of Exploration Greg Hahn joined Steve Darling from Proactive with some results from the company’s drill program at their Philadelphia project. Hahn discusses the next step the company is planning. Hahn also told Proactive they are...

39 minutes ago

2 min read